Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300067722Phase 4Not yet recruiting
Phase 4, randomised trial of remimazolam in orthopedic lower limb conditions requiring surgery (2 arms), sponsored by Mengcheng County No. 1 People's Hospital. Primary endpoints: Incidence of adverse reactions and Brain bispectral index (BIS). Planned start Jan 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300067722.